DeutschNewstral
Article
jdsupra.com on 2022-04-04 23:16
OIG Declines to Impose Sanctions Against Device Manufacturer’s Medicare Cost-Sharing Subsidy in Clinical Trial
Related news
- OIG Permits Medical Device Manufacturer’s Cost-Sharing Subsidies for Medicare Beneficiaries in Clinical Trialjdsupra.com
- OIG Approves Pharmaceutical Manufacturer’s Loaning of Smartphones to Support Digital Medicine (DM)jdsupra.com
- OIG Opines on Subsidizing Medicare Cost-Sharing for Clinical Trialsjdsupra.com
- OIG Advisory Opinion Approves Patient Subsidies For Clinical Studyjdsupra.com
- OIG Nixes Pharmaceutical Cost-Sharing Subsidy Program Under AKSjdsupra.com
- OIG Determines a Drug Manufacturer’s Initiative to Cover Certain Patients’ Transportation Costs Poses Low Risk of Fraud and Abusejdsupra.com
- OIG Approves Subsidies to Medicare Beneficiaries Provided by a Clinical Research Studyjdsupra.com
- New OIG Studies Reveal Clinical Lab Test Payment Trends and CMS’ Progress in Implementing PAMAjdsupra.com
- OIG Raises Concerns Regarding Accuracy of New Clinical Laboratory Payment Systemjdsupra.com
- OIG Advisory Opinion 15-07: An Indicator of Clinical Trial Copayment Change?jdsupra.com
- OIG Opinion: DME Supplier Subsidy of Medicare Cost-Sharing in Cardiac Trial OKjdsupra.com
- OIG Updates 2015 Work Plan: New medicare initiatives for hospitals, DMEPOS suppliers, clinical labs, GPOsjdsupra.com
- OIG Greenlights Manufacturer’s Limited Free Drug Programjdsupra.com
- OIG Declines to Approve Lab’s Payment of Specimen Collection Fees to Hospitalsjdsupra.com
- OIG Will Not Impose Administrative Sanctions for AKS Violations for Conduct Covered by Certain Blanket Waivers of the Stark Lawjdsupra.com
- OIG Issues Advisory Opinion Permitting Cost-Sharing for Medicare-Reimbursable Items and Services in a Clinical Trialjdsupra.com
- Advisory Opinion 22-08: OIG Declines to Impose Sanctions for Loaning of Smartphones for Receipt of Telehealth Servicesjdsupra.com
- OIG Will Not Impose Sanctions on Entities for Program That Provides Free Drugs to Patients Experiencing Delayed Insurance Approvalsjdsupra.com
- OIG Approves Manufacturer’s Offer of Free Genetic Testingjdsupra.com
- CMS finalizes site-neutral payment for clinic visits but declines to finalize clinical families payment limitationjdsupra.com